This article is more than 5 years old. Information may no longer be current.
Challenge calls for discovery of new insulin
Click Here to Manage Email Alerts
The Juvenile Diabetes Research Foundation and InnoCentive have announced a $100,000 challenge to look for innovative ways to approach the discovery and development of a glucose-responsive insulin as a means to treat insulin-dependent diabetes.
The challenge is open to the public, and researchers and scientists from outside the diabetes field are strongly encouraged to apply. Details on how to apply can be found on the InnoCentive website.
The ultimate goal is to discover a glucose-responsive insulin drug that would work only when the body needs it. Glucose-responsive insulin would deliver the precise amount of insulin needed in response to circulating glucose levels; improve glucose control; decrease or eliminate the need to test or monitor blood glucose levels; and reduce the changes of short- and long-term diabetic complications.
"What we need is sophisticated insulin that will take the guesswork out of managing diabetes by developing a novel insulin that works in the same way insulin works in people without diabetes," Aaron Kowalski, PhD, assistant vice president of treatment therapies at the Juvenile Diabetes Research Foundation, said in a press release. "By fostering novel approaches from diverse problem-solvers within and outside the diabetes field, we hope this challenge with InnoCentive will help speed progress toward the development of glucose-responsive insulin - progress urgently needed by people with diabetes."
Submissions will be accepted through Nov. 9. The winning solution could be further developed into a second phase, which would require a detailed research plan proposal and could offer the winning person the opportunity to become a member of the team created to put the winning solution into practice, according to the press release.
 |
Follow EndocrineToday.com on Twitter. |